JENNIFER LIM: Open Payments
NPI 1881478907 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 32 payments from 18 companies in 2025. Trend: 2023 $93 · 2024 $351 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $74 |
| Daiichi Sankyo Inc. | 3 | $72 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $62 |
| Novo Nordisk Inc | 3 | $57 |
| PFIZER INC. | 2 | $39 |
| Noven Therapeutics, LLC | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| AstraZeneca Pharmaceuticals LP | 2 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| ALK-Abello, Inc | 1 | $22 |
Products named: Veozah, INJECTAFER, XIFAXAN, Rybelsus, Xelstrym, VOQUEZNA, AIRSUPRA, JARDIANCE.
Industry payments across FL — which companies pay providers there.
